[Protocol for the study and treatment of immune thrombocytopenic purpura (ITP). ITP-2010]

E Monteagudo; R Fernández-Delgado; A Sastre; T Toll; A Llort; J Molina; I Astigarraga; M A Dasí; A Cervera; Grupo de Trabajo de la PTI de la Sociedad Española de Hematología y Oncología Pediátricas

doi:10.1016/j.anpedi.2010.11.004

[Protocol for the study and treatment of immune thrombocytopenic purpura (ITP). ITP-2010]

An Pediatr (Barc). 2011 Jun;74(6):414.e1-8. doi: 10.1016/j.anpedi.2010.11.004. Epub 2011 Mar 24.

[Article in Spanish]

Authors

E Monteagudo¹, R Fernández-Delgado, A Sastre, T Toll, A Llort, J Molina, I Astigarraga, M A Dasí, A Cervera; Grupo de Trabajo de la PTI de la Sociedad Española de Hematología y Oncología Pediátricas

Affiliation

¹ Unidad de Hematología Pediátrica, Hospital Infantil La Fe, Valencia, Spain. [email protected]

PMID: 21439923
DOI: 10.1016/j.anpedi.2010.11.004

Abstract

Primary immune thrombocytopenia (ITP), formerly known as immune thrombocytopenic purpura, is a disease in which clinical and therapeutic management has always been controversial. The ITP working group of the Spanish Society of Paediatric Haematology and Oncology has updated its guidelines for diagnosis and treatment of ITP in children based on current guidelines, literature review, clinical trials and member consensus. The primary objective was to lessen clinical variability in diagnostic and therapeutic procedures in order to obtain best clinical results with minimal adverse events and good quality of life.

Publication types

English Abstract
Practice Guideline

MeSH terms

Clinical Protocols
Decision Trees
Humans
Purpura, Thrombocytopenic / diagnosis*
Purpura, Thrombocytopenic / immunology
Purpura, Thrombocytopenic / therapy